Search results
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance Canada· 3 months agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) showcases robust revenue growth and solid operational...
Travere (TVTX) Stock Up More Than 30% in 3 Months: Here's Why
Zacks via Yahoo Finance Canada· 6 months agoTravere (TVTX) is on track to file an sNDA to the FDA to convert the accelerated approval for lead...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance Canada· 2 months agoWith the end of the first-quarter earnings season, the focus has now shifted to pipeline and...
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 5 months agoTravere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2023 Earnings Call Transcript February 16, 2024 Travere...
VERA Dips Despite Positive Data From IgA Nephropathy Study
Zacks via Yahoo Finance Canada· 2 years agoVera Therapeutics, Inc. VERA announced positive top-line data from the phase IIb ORIGIN study...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 4 months agoAlpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2023 Earnings Call Transcript March 18, 2024 Alpine...
Biotech Stock Roundup: KDNY Up on NVS Buyout, BIIB & Eisai's AD Drug Update & More
Zacks via Yahoo Finance Canada· 1 year agoIt was a busy week for the biotech sector. Key regulatory and pipeline updates from bigwigs like...
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 3 months agoKrystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript May 6, 2024 Krystal Biotech,...
Arcutis (ARQT) Up on Top-Line Data From Atopic Dermatitis Study
Zacks via Yahoo Finance Canada· 2 years agoArcutis Biotherapeutics (ARQT) reports positive top-line data from a phase III study of its lead...
Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 4 months agoVaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript March 14, 2024 Vaxart, Inc. isn’t one of...